Evidence map›Paper›PMID 33654308›Full record

ArticleNature reviews. Rheumatology2021

Moving towards a molecular categorization of autoimmune disease.

Michael L Whitfield

Abstract readComment
PubMed Publisher
In one paragraph

Article in Nature reviews. Rheumatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Michael L WhitfieldDepartment of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. Michael.L.Whitfield@dartmouth.edu.ORCID http://orcid.org/0000-0002-0862-6003

Funding

Zhao - Proj 2P20GM130454 · NIGMS · DARTMOUTH COLLEGE · PI Chengxiang Qiu · 2019 to 2026
$27.2M
Translational studies for identifying and targeting novel pathways in systemic sclerosis pathogenesisP50AR060780 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LAFYATIS, ROBERT A. · 2011 to 2021
$14.9M
Complex 3-Dimensional in vitro Human Skin Tissue Models for SclerodermaR44AR072170 · NIAMS · CELDARA MEDICAL, LLC · PI MURAD, JOANA M · 2018 to 2019
$1.5M
Cellular Immunotherapy for Systemic SclerosisR44AR073067 · NIAMS · CELDARA MEDICAL, LLC · PI MURAD, JOANA M · 2019 to 2020
$1.5M
NIAMS NIH HHS R44 AR072170NIAMS NIH HHS R44 AR073067NIGMS NIH HHS P20 GM130454
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Autoimmune DiseasesHumans

Identifiers

PMID33654308

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.